ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey (ID 33)

Q&A and discussion (ID 333)

Lecture Time
19:15 - 19:30
Speakers
  • All Speakers (na, Swaziland)
Authors
  • All Speakers (na, Swaziland)
Session Name
ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey (ID 33)
Room
Munich Hall
Date
Tue, 03.05.2022
Time
18:00 - 19:35